|
Oct 9
|
Kintara Therapeutics Reveals Improved Financials, Merger Plans
|
|
Oct 8
|
Kintara Therapeutics Announces Fiscal 2024 Financial Results and Provides Corporate Update
|
|
Aug 19
|
TuHURA Biosciences and Kintara Therapeutics Announce Kineta Inc. Reopens Enrollment for VISTA-101 Clinical Trial Evaluating KVA12123 in Patients with Advanced Solid Tumor Cancer
|
|
Feb 12
|
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial for the Treatment of Cutaneous Metastatic Breast Cancer
|
|
Dec 7
|
Kintara Therapeutics Announces Review of Strategic Alternatives
|
|
Dec 5
|
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders' Equity Continued Listing Requirement
|
|
Aug 9
|
Kintara Therapeutics to Present at the Emerging Growth Conference
|
|
Aug 8
|
Presenting on the Emerging Growth Conference on August 9 & 10 Register Now
|